This drug, an antipsychotic used in the treatment of refractory schizophrenia with frequent severe side effects, is mainly metabolized by CYP1A2, resulting in two metabolites with different toxicological and pharmacological profiles [66]. This evidence concerns the gene CYP1A2 and schizophrenia.